CVRx, Inc. (CVRX): Cost of Revenue

Annual figures by period end, from SEC filings.

$8.31M
Year ended 2025-12-31
$8.01M
Trailing 12 months to 2026-06-30
+18.5%
3-year compound annual growth
+42.0%
5-year compound annual growth
$8.33M2020-12-31: $1.44M2021-12-31: $3.64M2022-12-31: $5.00M2023-12-31: $6.26M2024-12-31: $8.33M2025-12-31: $8.31M$8.31M
2020-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$8.31M-0.3%2026-02-13, From 2025-01-01
2024-12-31$8.33M+33.2%2026-02-13, From 2024-01-01
2023-12-31$6.26M+25.1%2025-02-18, From 2023-01-01
2022-12-31$5.00M+37.3%2024-02-09, From 2022-01-01
2021-12-31$3.64M+152.8%2023-02-10, From 2021-01-01
2020-12-31$1.44Mn/a2022-02-22, From 2020-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
CVRx, Inc. (CVRX)2025-12-31$8.31M-0.3%
LENSAR, Inc. (LNSR)2025-12-31$31.31M+13.3%
Apyx Medical Corp (APYX)2025-12-31$19.80M+5.6%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$42.63M-33.0%
Carlsmed, Inc. (CARL)2025-12-31$12.47M+75.2%
Shoulder Innovations, Inc. (SI)2025-12-31$11.12M+52.6%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$6.96M+69.8%
AVITA Medical, Inc. (RCEL)2025-12-31$12.79M+40.7%
SANUWAVE Health, Inc. (SNWV)2025-12-31$10.08M+24.7%

Compare CVRX, LNSR, APYX, MHUAF side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗